Expert opinion in melanoma: The sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2736-2742

  van Akkooi, Alexander C J ^a,e   Spatz, Alain ^b,e   Eggermont, Alexander M M ^a,e   Mihm, Martin ^c,e   Cook, Martin G ^d,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SURREY   (United Kingdom)

^e EORTC Melanoma Group   (Belgium)

Author keywords

Lymphadenectomy; Measurements; Melanoma; Methodology; Microanatomic location; Recommendations; Sentinel node; Sentinel nodes; Tumour burden; Tumour load

Indexed keywords

ARTICLE; CANCER SURVIVAL; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHADENECTOMY; MEASUREMENT; MELANOMA; METASTASIS; PARENCHYMA; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY;

CLINICAL PROTOCOLS; HUMANS; LYMPHATIC METASTASIS; MELANOMA; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 70350013571     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.015     Document Type: Article

References (31)

1. Cook M.G., Green M.A., Anderson B., et al. The development of optimal pathological assessment of sentinel lymph nodes for melanoma. J Pathol 200 (2003) 314-319
2. Doubrovsky A., De Wilt J.H., Scolyer R.A., et al. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma. Ann Surg Oncol 11 (2004) 829-836
3. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience. the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 17 (1999) 976-983
4. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. New Engl J Med 355 (2006) 1307-1317
5. Ruiter D.J., Spatz A., van den Oord J.J., et al. Pathologic staging of melanoma. Semin Oncol 29 (2002) 370-381
6. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 42 (2006) 372-380
7. Kretschmer L., Beckmann I., Thoms K.M., et al. Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas. Eur J Cancer 41 (2005) 531-538
8. Ranieri J.M., Wagner J.D., Azuaje R., et al. Prognostic importance of lymph node tumor burden in melanoma patients staged by sentinel node biopsy. Ann Surg Oncol 9 (2002) 975-981
9. Carlson G.W., Murray D.R., Lyles R.H., et al. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?. Ann Surg Oncol 10 (2003) 575-581
10. Reeves M.E., Delgado R., Busam K.J., et al. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol 10 (2003) 27-31
11. Starz H., Siedlecki K., and Balda B.R. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 11 (2004) 162S-168S
12. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 22 (2004) 3345-3349
13. Vuylsteke R.J., Borgstein P.J., van Leeuwen P.A., et al. Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma. Ann Surg Oncol 12 (2005) 440-448
14. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 (2005) 37-47
15. Pearlman N.W., McCarter M.D., Frank M., et al. Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma. Am J Surg 192 (2006) 878-881
16. van Akkooi A.C., de Wilt J.H., Verhoef C., et al. Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?. Ann Oncol 17 (2006) 1578-1585
17. Govindarajan A., Ghazarian D.M., McCready D.R., et al. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse. Ann Surg Oncol 14 (2007) 906-912
18. Satzger I., Volker B., Al Ghazal M., et al. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 50 (2007) 764-772
19. Debarbieux S., Duru G., Dalle S., et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 157 (2007) 58-67
20. Scheri R.P., Essner R., Turner R.R., et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol 14 (2007) 2861-2866
21. Gershenwald J.E., Andtbacka R.H., Prieto V.G., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26 (2008) 4296-4303
22. van Akkooi A.C.J., Nowecki Z., Voit C., et al. Minimal sentinel node (SN) tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients. A multicenter study in 388 SN positive patients. Ann Surg (2008) 248
23. Starz H., Balda B.R., Kramer K.U., et al. Cancer 91 (2001) 2110-2121
24. Cochran A.J., Wen D.R., Huang R.R., et al. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol 17 (2004) 747-755
25. Thomas J.M. Sentinel-node biopsy in melanoma. New Engl J Med 356 (2007) 418 [author reply 419-21]
26. Thomas J.M. Prognostic false-positivity of the sentinel node in melanoma. Nat Clin Pract Oncol 5 (2008) 18-23
27. van Akkooi A.C., de Wilt J.H., Voit C., et al. Sentinel lymph-node false positivity in melanoma. Nat Clin Pract Oncol 5 (2008) E2
28. de Wilt JH, van Akkooi AC, Verhoef C, et al. Detection of melanoma micrometastases in sentinel nodes - the cons. Surg Oncol 2008.
29. Morton D.L., Cochran A.J., and Thompson J.F. The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 5 (2008) 510-511
30. Scolyer R.A., Murali R., Gershenwald J.E., et al. Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell. Ann Oncol 18 (2007) 806-808
31. Scolyer R.A., Murali R., Satzger I., et al. The detection and significance of melanoma micrometastases in sentinel nodes. Surg Oncol 17 (2008) 165-174